Mock James M has filed 116 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 11797 shares of Moderna, Inc. ($MRNA) on March 05, 2026.
Activity breakdown: 0 open-market purchases and 12 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 11797 | $0.00 | 129,774.0000 | 389,000,000 | 8.33% | 0.00% |
| March 5, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 11797 | $0.00 | 62,702.0000 | 389,000,000 | 23.17% | 0.00% |
| March 5, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 5704 | $57.80 | 56,998.0000 | 389,000,000 | 9.10% | 0.00% |
| March 1, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Stock Option (Right to Buy) | 37639 | $0.00 | 37,639.0000 | 389,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 774 | $0.00 | 46,167.0000 | 389,000,000 | 1.71% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 375 | $51.71 | 45,792.0000 | 389,000,000 | 0.81% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 9901 | $0.00 | 55,693.0000 | 389,000,000 | 21.62% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 4788 | $51.71 | 50,905.0000 | 389,000,000 | 8.60% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 329 | $0.00 | 1,315.0000 | 389,000,000 | 20.01% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 774 | $0.00 | 6,189.0000 | 389,000,000 | 11.12% | 0.00% |
| March 1, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Restricted Stock Units | 49569 | $0.00 | 49,569.0000 | 389,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 9901 | $0.00 | 29,705.0000 | 389,000,000 | 25.00% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 329 | $0.00 | 45,553.0000 | 389,000,000 | 0.73% | 0.00% |
| Feb. 27, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 160 | $51.71 | 45,393.0000 | 389,000,000 | 0.35% | 0.00% |
| Feb. 11, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Common Stock | 2630 | $0.00 | 46,502.0000 | 389,000,000 | 5.99% | 0.00% |
| Feb. 11, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 1278 | $41.99 | 45,224.0000 | 389,000,000 | 2.75% | 0.00% |
| Jan. 5, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1452 | $0.00 | 4,359.0000 | 389,000,000 | 24.99% | 0.00% |
| Jan. 5, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1452 | $0.00 | 44,652.0000 | 389,000,000 | 3.36% | 0.00% |
| Jan. 5, 2026 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 780 | $30.86 | 43,872.0000 | 389,000,000 | 1.75% | 0.00% |
| Dec. 5, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 22817 | $25.49 | 43,200.0000 | 390,000,000 | 34.56% | 0.01% |
| Dec. 5, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 47190 | $0.00 | 66,017.0000 | 390,000,000 | 250.65% | 0.01% |
| Dec. 5, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 47190 | $0.00 | 141,571.0000 | 390,000,000 | 25.00% | 0.01% |
| Nov. 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 329 | $0.00 | 18,987.0000 | 390,000,000 | 1.76% | 0.00% |
| Nov. 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 329 | $0.00 | 1,644.0000 | 390,000,000 | 16.68% | 0.00% |
| Nov. 26, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 773 | $0.00 | 6,963.0000 | 390,000,000 | 9.99% | 0.00% |
| Nov. 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 160 | $25.01 | 18,827.0000 | 390,000,000 | 0.84% | 0.00% |
| Nov. 26, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 374 | $24.75 | 18,658.0000 | 390,000,000 | 1.97% | 0.00% |
| Nov. 26, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 773 | $0.00 | 19,032.0000 | 390,000,000 | 4.23% | 0.00% |
| Oct. 3, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 703 | $28.37 | 18,259.0000 | 390,000,000 | 3.71% | 0.00% |
| Oct. 3, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1453 | $0.00 | 5,811.0000 | 390,000,000 | 20.00% | 0.00% |
| Oct. 3, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1453 | $0.00 | 18,962.0000 | 390,000,000 | 8.30% | 0.00% |
| Aug. 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 160 | $25.10 | 17,509.0000 | 384,000,000 | 0.91% | 0.00% |
| Aug. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 774 | $0.00 | 17,715.0000 | 384,000,000 | 4.57% | 0.00% |
| Aug. 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 329 | $0.00 | 17,669.0000 | 384,000,000 | 1.90% | 0.00% |
| Aug. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 375 | $24.73 | 17,340.0000 | 384,000,000 | 2.12% | 0.00% |
| Aug. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 774 | $0.00 | 7,736.0000 | 384,000,000 | 9.10% | 0.00% |
| Aug. 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 329 | $0.00 | 1,973.0000 | 384,000,000 | 14.29% | 0.00% |
| July 3, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 703 | $30.28 | 16,941.0000 | 384,000,000 | 3.98% | 0.00% |
| July 3, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1453 | $0.00 | 17,644.0000 | 384,000,000 | 8.97% | 0.00% |
| July 3, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1453 | $0.00 | 7,264.0000 | 384,000,000 | 16.67% | 0.00% |
| May 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 159 | $26.76 | 16,191.0000 | 384,000,000 | 0.97% | 0.00% |
| May 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 328 | $0.00 | 2,302.0000 | 384,000,000 | 12.47% | 0.00% |
| May 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 773 | $0.00 | 16,396.0000 | 384,000,000 | 4.95% | 0.00% |
| May 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 328 | $0.00 | 16,350.0000 | 384,000,000 | 2.05% | 0.00% |
| May 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 773 | $0.00 | 8,510.0000 | 384,000,000 | 8.33% | 0.00% |
| May 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 374 | $26.26 | 16,022.0000 | 384,000,000 | 2.28% | 0.00% |
| April 4, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1452 | $0.00 | 16,326.0000 | 384,000,000 | 9.76% | 0.00% |
| April 4, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 703 | $25.73 | 15,623.0000 | 384,000,000 | 4.31% | 0.00% |
| April 4, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1452 | $0.00 | 8,717.0000 | 384,000,000 | 14.28% | 0.00% |
| Feb. 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 329 | $0.00 | 2,630.0000 | 384,000,000 | 11.12% | 0.00% |
| Feb. 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 329 | $0.00 | 15,034.0000 | 384,000,000 | 2.24% | 0.00% |
| Feb. 28, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 160 | $31.09 | 14,874.0000 | 384,000,000 | 1.06% | 0.00% |
| March 1, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Stock Option (Right to Buy) | 63478 | $0.00 | 63,478.0000 | 384,000,000 | 9999.99% | 0.02% |
| March 1, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Restricted Stock Units | 39606 | $0.00 | 39,606.0000 | 384,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1326 | $0.00 | 0.0000 | 384,000,000 | 100.00% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 642 | $33.58 | 12,423.0000 | 384,000,000 | 4.91% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1326 | $0.00 | 13,065.0000 | 384,000,000 | 11.30% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 3094 | $0.00 | 15,517.0000 | 384,000,000 | 24.91% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 1496 | $33.58 | 14,021.0000 | 384,000,000 | 9.64% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1326 | $0.00 | 15,347.0000 | 384,000,000 | 9.46% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 642 | $33.58 | 14,705.0000 | 384,000,000 | 4.18% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Performance Stock Units | 1326 | $0.00 | 0.0000 | 384,000,000 | 100.00% | 0.00% |
| Feb. 27, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 3094 | $0.00 | 9,283.0000 | 384,000,000 | 25.00% | 0.00% |
| Jan. 3, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | F | Common Stock | 780 | $42.00 | 11,739.0000 | 384,000,000 | 6.23% | 0.00% |
| Jan. 3, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1453 | $0.00 | 12,519.0000 | 384,000,000 | 13.13% | 0.00% |
| Jan. 3, 2025 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1453 | $0.00 | 10,169.0000 | 384,000,000 | 12.50% | 0.00% |
| Dec. 5, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Restricted Stock Units | 188761 | $0.00 | 188,761.0000 | 399,000,000 | 9999.99% | 0.05% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1326 | $0.00 | 10,831.0000 | 399,000,000 | 13.95% | 0.00% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 329 | $0.00 | 11,160.0000 | 399,000,000 | 3.04% | 0.00% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1326 | $0.00 | 12,486.0000 | 399,000,000 | 11.88% | 0.00% |
| Nov. 29, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 1420 | $42.79 | 11,066.0000 | 399,000,000 | 11.37% | 0.00% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Performance Stock Units | 1326 | $0.00 | 1,326.0000 | 399,000,000 | 50.00% | 0.00% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1326 | $0.00 | 1,326.0000 | 399,000,000 | 50.00% | 0.00% |
| Nov. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 329 | $0.00 | 2,959.0000 | 399,000,000 | 10.01% | 0.00% |
| Oct. 4, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1453 | $0.00 | 11,622.0000 | 399,000,000 | 11.11% | 0.00% |
| Oct. 4, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1453 | $0.00 | 10,220.0000 | 399,000,000 | 16.57% | 0.00% |
| Oct. 7, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 715 | $60.12 | 9,505.0000 | 399,000,000 | 7.00% | 0.00% |
| Aug. 29, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 162 | $78.03 | 8,767.0000 | 382,000,000 | 1.81% | 0.00% |
| Aug. 28, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 329 | $0.00 | 8,929.0000 | 382,000,000 | 3.83% | 0.00% |
| Aug. 28, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 329 | $0.00 | 3,288.0000 | 382,000,000 | 9.10% | 0.00% |
| Aug. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1326 | $0.00 | 2,652.0000 | 382,000,000 | 33.33% | 0.00% |
| Aug. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Performance Stock Units | 1326 | $0.00 | 2,652.0000 | 382,000,000 | 33.33% | 0.00% |
| Aug. 28, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 1321 | $79.39 | 8,600.0000 | 382,000,000 | 13.32% | 0.00% |
| Aug. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1326 | $0.00 | 9,921.0000 | 382,000,000 | 15.43% | 0.00% |
| Aug. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1326 | $0.00 | 8,595.0000 | 382,000,000 | 18.24% | 0.00% |
| July 8, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 689 | $118.24 | 7,269.0000 | 382,000,000 | 8.66% | 0.00% |
| July 5, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1452 | $0.00 | 13,075.0000 | 382,000,000 | 10.00% | 0.00% |
| July 5, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1452 | $0.00 | 7,958.0000 | 382,000,000 | 22.32% | 0.00% |
| May 31, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Performance Stock Units | 1326 | $0.00 | 3,978.0000 | 382,000,000 | 25.00% | 0.00% |
| May 31, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Performance Stock Units | 5304 | $0.00 | 5,304.0000 | 382,000,000 | 9999.99% | 0.00% |
| June 3, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 691 | $140.72 | 6,506.0000 | 382,000,000 | 9.60% | 0.00% |
| May 31, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1326 | $0.00 | 7,197.0000 | 382,000,000 | 22.59% | 0.00% |
| May 28, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 328 | $0.00 | 3,617.0000 | 382,000,000 | 8.31% | 0.00% |
| May 28, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 328 | $0.00 | 6,054.0000 | 382,000,000 | 5.73% | 0.00% |
| May 29, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 183 | $144.50 | 5,871.0000 | 382,000,000 | 3.02% | 0.00% |
| May 24, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1326 | $0.00 | 3,978.0000 | 382,000,000 | 25.00% | 0.00% |
| May 24, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1326 | $0.00 | 6,374.0000 | 382,000,000 | 26.27% | 0.00% |
| May 28, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 648 | $162.47 | 5,726.0000 | 382,000,000 | 10.17% | 0.00% |
| April 5, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1453 | $0.00 | 14,527.0000 | 382,000,000 | 9.09% | 0.00% |
| April 5, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1453 | $0.00 | 5,753.0000 | 382,000,000 | 33.79% | 0.00% |
| April 8, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 705 | $101.93 | 5,048.0000 | 382,000,000 | 12.25% | 0.00% |
| Feb. 28, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1315 | $0.00 | 3,945.0000 | 382,000,000 | 25.00% | 0.00% |
| Feb. 29, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 647 | $94.57 | 4,300.0000 | 382,000,000 | 13.08% | 0.00% |
| Feb. 28, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1315 | $0.00 | 4,947.0000 | 382,000,000 | 36.21% | 0.00% |
| Feb. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Restricted Stock Units | 12377 | $0.00 | 12,377.0000 | 382,000,000 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Restricted Stock Units | 5304 | $0.00 | 5,304.0000 | 382,000,000 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Stock Option (Right to Buy) | 60216 | $0.00 | 60,216.0000 | 382,000,000 | 9999.99% | 0.02% |
| Feb. 27, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Stock Option (Right to Buy) | 23635 | $0.00 | 23,635.0000 | 382,000,000 | 9999.99% | 0.01% |
| Jan. 5, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 1452 | $0.00 | 4,404.0000 | 382,000,000 | 49.19% | 0.00% |
| Jan. 8, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 772 | $109.75 | 3,632.0000 | 382,000,000 | 17.53% | 0.00% |
| Jan. 5, 2024 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 1452 | $0.00 | 15,980.0000 | 382,000,000 | 8.33% | 0.00% |
| Oct. 5, 2023 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Restricted Stock Units | 5810 | $0.00 | 17,432.0000 | 416,000,000 | 25.00% | 0.00% |
| Oct. 5, 2023 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | M | Common Stock | 5810 | $0.00 | 5,810.0000 | 416,000,000 | 9999.99% | 0.00% |
| Oct. 6, 2023 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | S | Common Stock | 2858 | $102.50 | 2,952.0000 | 416,000,000 | 49.19% | 0.00% |
| Feb. 28, 2023 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Stock Option (Right to Buy) | 20040 | $0.00 | 20,040.0000 | 416,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Moderna, Inc. | $MRNA | Mock James M | Chief Financial Officer | A | Restricted Stock Units | 5260 | $0.00 | 5,260.0000 | 416,000,000 | 9999.99% | 0.00% |